Dr.Diary., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dr.Diary., Ltd. - overview
Established
2017
Location
Seoul, -, South Korea
Primary Industry
Healthcare IT
About
Founded in 2017 and based in Seoul, South Korea, Dr. Diary. , Ltd. is a digital healthcare company specializing in diabetes management.
In March 2022, Dr. Diary. , Ltd. raised KRW 14.
7 billion in Series B funding from Devsisters Ventures, Insight Equity Partners, Korea Investment Partners, Shinhan Investment Corp. , Smilegate Investment, and We Venture Partners. Je-Yoon Song is the CEO of the company. The company offers Dr.
Diary, a chronic disease management healthcare platform in which the artificial intelligence assistant Didi informs personalized management methods based on the records entered. The firm delivers all products needed for management, from customized diabetic diets to blood glucose meters. Dr. Diary.
, Ltd. generates revenue through their blood sugar test paper subscription service, where individually customized content is optimized for diabetic people's various health management situations. The organization plans to use the February 2022 investment to build its own multi-solution smart coaching ecosystem and secure professional manpower for business model expansion and expand its capabilities in marketing, and focus on platform stability and data advancement.
Current Investors
Primer, AlpenRoute Asset Management, Korea Investment Partners
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software
Website
www.drdiary.co.kr
Verticals
HealthTech, Mobile Apps
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.